What are the primary results of the CHAMP study?
The primary results of the CHAMP study, which compared combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction, were published in Circulation. The results showed that warfarin combined with aspirin was more effective in preventing mortality than aspirin alone. Additionally, the results showed that warfarin combined with aspirin was associated with a lower risk of stroke and major bleeding compared to aspirin alone. Furthermore, the study showed that warfarin combined with aspirin was more effective in preventing mortality than aspirin alone in all age groups and in both sexes.